FDA vetoes Novo Nordisk insulin drug

Home › FDA vetoes Novo Nordisk insulin drug

The new long-acting insulin Tresiba drug is seen on a Novo Nordisk production line, in this 2012 handout picture provided by Novo Nordisk.

15.05	Exploring the future of agriculture
15.05	American, Mexican, and Canadian cattle producers sign joint statement
15.05	Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05	Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05	Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05	KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05	TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05	Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
More »

je.st